Skip to main content UVA Health School of Medicine Logo UVA Health School of Medicine Logo
The Making of Medicine

Tag: Frederick G. Hayden

Frederick G. Hayden, MD, examined the effectiveness of a new anti-flu drug, baloxavir marboxil, also known as Xofluza.
The First New Flu Drug in 20 Years
October 26, 2018

The federal Food and Drug Administration has approved a new single-dose drug, baloxavir marboxil, that can shorten the duration of the flu. It's the first new drug of its type in 20 years. Our Frederick G. Hayden, MD, and his colleagues found that the drug, developed by pharma company Shinogi,…

Frederick G. Hayden, MD, examined the effectiveness of a new anti-flu drug, baloxavir marboxil, also known as Xofluza.
One Dose to Shorten the Flu
September 8, 2018

A single dose of a new drug can shorten the duration of flu symptoms by about a day, according to a new paper published by our Frederick G. Hayden, MD, and colleagues. The drug, baloxavir marboxil, appears to reduce symptom duration by about the same amount as an existing drug,…